JP2006523239A5 - - Google Patents

Download PDF

Info

Publication number
JP2006523239A5
JP2006523239A5 JP2006509883A JP2006509883A JP2006523239A5 JP 2006523239 A5 JP2006523239 A5 JP 2006523239A5 JP 2006509883 A JP2006509883 A JP 2006509883A JP 2006509883 A JP2006509883 A JP 2006509883A JP 2006523239 A5 JP2006523239 A5 JP 2006523239A5
Authority
JP
Japan
Prior art keywords
group
hydrogen
following formula
pharmaceutical composition
protecting group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006509883A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006523239A (ja
JP5005340B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/011059 external-priority patent/WO2004092118A2/en
Publication of JP2006523239A publication Critical patent/JP2006523239A/ja
Publication of JP2006523239A5 publication Critical patent/JP2006523239A5/ja
Application granted granted Critical
Publication of JP5005340B2 publication Critical patent/JP5005340B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006509883A 2003-04-10 2004-04-09 2−プロピリデン−19−ノル−ビタミンd化合物 Expired - Fee Related JP5005340B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46195803P 2003-04-10 2003-04-10
US60/461,958 2003-04-10
PCT/US2004/011059 WO2004092118A2 (en) 2003-04-10 2004-04-09 2-propylidene-19-nor-vitamin d compounds

Publications (3)

Publication Number Publication Date
JP2006523239A JP2006523239A (ja) 2006-10-12
JP2006523239A5 true JP2006523239A5 (https=) 2007-04-19
JP5005340B2 JP5005340B2 (ja) 2012-08-22

Family

ID=33299883

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006509883A Expired - Fee Related JP5005340B2 (ja) 2003-04-10 2004-04-09 2−プロピリデン−19−ノル−ビタミンd化合物

Country Status (14)

Country Link
US (3) US20060293291A1 (https=)
EP (1) EP1613588B1 (https=)
JP (1) JP5005340B2 (https=)
KR (1) KR20050120787A (https=)
CN (2) CN101293894B (https=)
AT (1) ATE556999T1 (https=)
AU (1) AU2004230948A1 (https=)
BR (1) BRPI0409194A (https=)
CA (1) CA2516233C (https=)
MX (1) MXPA05009336A (https=)
MY (1) MY146504A (https=)
NZ (1) NZ542674A (https=)
WO (1) WO2004092118A2 (https=)
ZA (1) ZA200506204B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0409194A (pt) * 2003-04-10 2006-04-11 Wisconsin Alumni Res Found compostos, composição farmacêutica e método de tratamento de doença metabólica do osso, da psorìase, da leucemia, cáncer do cólon, cáncer da mama, cáncer da pele ou cáncer da próstata, de doença auto-imune, de doença inflamatória do intestino e de aumento da resistência do osso
US7713951B2 (en) * 2004-04-09 2010-05-11 Wisconsin Alumni Research Foundation 2-alkylidene-18,19-dinor-vitamin D compounds
NZ561076A (en) * 2005-02-11 2010-01-29 Wisconsin Alumni Res Found 2-methylene-19-nor-(20S-24EPI)-1alpha,25-dihydroxyvitamin-D2
AU2006213727B2 (en) * 2005-02-11 2011-08-18 Wisconsin Alumni Research Foundation 2-methylene-19-nor- (20S-24S) - 1alpha, 25-dihydroxyvitamin-D2
US8114393B2 (en) 2005-09-14 2012-02-14 Wisconsin Alumni Research Foundation Methods and compositions for phosphate binding
EP2010483A2 (en) * 2006-04-05 2009-01-07 Wisconsin Alumni Research Foundation 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and use thereof
US20090281340A1 (en) * 2006-04-05 2009-11-12 Deluca Hector F 1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and treatment thereof
MX2008012671A (es) 2006-04-06 2008-10-15 Wisconsin Alumni Res Found Analogos 1 a,25-dihidroxi- 19, 26,27-trinor vitamina d 2-sustituidos y sus usos.
WO2008026078A2 (en) * 2006-04-06 2008-03-06 Wisconsin Alumni Research Foundation 19-nor-vitamin d analogs with 1,2,or 3,2 heterocyclic ring
JP2009533483A (ja) * 2006-04-06 2009-09-17 ウイスコンシン アラムニ リサーチ ファンデーション 2−メチレン−1α,25−ジヒドロキシ−18,19,21−トリノルビタミンD3およびその使用
US7648973B2 (en) * 2006-04-06 2010-01-19 Wisconsin Alumni Research Foundation 2-methylene-1α,25-dihydroxy-19,21-dinorvitamin D3 analogs and uses thereof
CA2646909A1 (en) * 2006-04-06 2008-03-27 Hector F. Deluca 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof
AU2007298651A1 (en) * 2006-04-06 2008-03-27 Wisconsin Alumni Research Foundation 2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin D3 analogs and uses thereof
DE602007012216D1 (de) 2006-04-10 2011-03-10 Wisconsin Alumni Res Found 1-alpha-hydroxy-2-(3'-hydroxypropyliden)-19-nor-vitamin-d-verbindungen mit einer 1,1-dimethylpropyl-seitenkette

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0078704B1 (en) 1981-11-02 1987-04-29 Research Institute For Medicine And Chemistry Inc. Intermediates in the synthesis of vitamin d derivatives
US4666634A (en) 1984-12-05 1987-05-19 Chugai Seiyaku Kabushiki Kaisha vitamin D3 derivatives having a substituent at 2-position
GB8904154D0 (en) 1989-02-23 1989-04-05 Leo Pharm Prod Ltd Chemical compounds
CA1333616C (en) 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
US5246925A (en) * 1989-03-09 1993-09-21 Wisconsin Alumni Research Foundation 19-nor-vitamin D compounds for use in treating hyperparathyroidism
NZ232734A (en) 1989-03-09 1991-11-26 Wisconsin Alumni Res Found 19-nor vitamin d derivatives and pharmaceutical compositions
AU649057B2 (en) 1990-08-24 1994-05-12 Wisconsin Alumni Research Foundation Methods and compositions containing vitamin D compounds for improvement of skin conditions
DE69130497T2 (de) 1990-09-07 1999-04-22 Wisconsin Alumni Research Foundation, Madison, Wis. Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
AU650751B2 (en) 1991-05-28 1994-06-30 Wisconsin Alumni Research Foundation Novel synthesis of 19-nor vitamin D compounds
US5086191A (en) 1991-05-28 1992-02-04 Wisconsin Alumni Research Foundation Intermediates for the synthesis of 19-nor vitamin D compounds
JP3213092B2 (ja) * 1991-11-01 2001-09-25 中外製薬株式会社 2β位に置換基を有するビタミンD誘導体
DE69400495T2 (de) 1993-04-05 1997-04-30 Wisconsin Alumni Res Found 19-Nor-vitamin-D3-Verbindung mit einem Substituent an die 2. Stelle
US5565589A (en) * 1993-11-03 1996-10-15 Wisconsin Alumni Research Foundation 17-formyl-5,6-trans-vitamin D compounds
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
WO1996001811A1 (en) * 1994-07-11 1996-01-25 The Johns-Hopkins University 2-substituted 1,25-dihydroxyvitamin d3 derivatives
EP0793649B1 (en) 1994-11-21 1999-02-03 Wisconsin Alumni Research Foundation 18,19-dinor-vitamin d compounds
US5877168A (en) * 1995-02-10 1999-03-02 Chugai Seiyaku Kabushiki Kaisha Vitamin D derivative with substituent at the 2β-position
CA2175881A1 (en) * 1995-05-09 1996-11-10 Andrzej Kutner Vitamin d compounds and methods of preparing these compounds
US5843928A (en) * 1997-03-17 1998-12-01 Wisconsin Alumni Research Foundation 2-alkylidene-19-nor-vitamin D compounds
US6392071B1 (en) * 1997-03-17 2002-05-21 Wisconsin Alumni: Research Foundation 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
US5945410A (en) 1997-03-17 1999-08-31 Wisconsin Alumni Research Foundation 2-alkyl-19-nor-vitamin D compounds
GB9915839D0 (en) * 1999-07-06 1999-09-08 Textron Automotive U K Valve assembly for vehicle washing system
US6806262B2 (en) * 2000-05-31 2004-10-19 Wisconsin Alumni Research Foundation 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
EP1524264A3 (en) * 2000-05-31 2010-01-20 Wisconsin Alumni Research Foundation 2-ethylidene-19-nor-vitamin D compounds
US6846811B2 (en) * 2002-04-22 2005-01-25 Wisconsin Alumni Research Foundation (20S) 1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses
BRPI0409194A (pt) * 2003-04-10 2006-04-11 Wisconsin Alumni Res Found compostos, composição farmacêutica e método de tratamento de doença metabólica do osso, da psorìase, da leucemia, cáncer do cólon, cáncer da mama, cáncer da pele ou cáncer da próstata, de doença auto-imune, de doença inflamatória do intestino e de aumento da resistência do osso
US7053075B2 (en) * 2003-11-25 2006-05-30 Deluca Hector F Methods for reducing body fat using vitamin D compounds

Similar Documents

Publication Publication Date Title
JP2006523239A5 (https=)
JP2019522055A5 (https=)
JP2019031560A5 (https=)
JP2012504133A5 (https=)
JP2004509853A5 (https=)
JP2018530549A5 (https=)
JP2010500293A5 (https=)
JP2008195730A5 (https=)
JP2007533741A5 (ja) Bace阻害剤として有用なピロリジン誘導体
JP2010077141A5 (https=)
JP2013510825A5 (https=)
JP2010526814A5 (https=)
JP2004524340A5 (https=)
JP2019516739A5 (https=)
JP2010523623A5 (https=)
JP2009504748A5 (https=)
JP2009541224A5 (https=)
JP2007522142A5 (https=)
JP2007502832A5 (https=)
JP2007508298A5 (https=)
JP2019529460A5 (https=)
CA2516233A1 (en) 2-propylidene-19-nor-vitamin d compounds
JP2007515467A5 (https=)
JP2008520690A5 (https=)
JP2010535706A5 (https=)